Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone.

about

Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone.

Item

http://www.wikidata.org/entity/Q47252724

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Salvage re-irradiation for rec ...... mparison to bevacizumab alone.

@en

Salvage re-irradiation for rec ...... mparison to bevacizumab alone.

@nl

type

Item

label

Salvage re-irradiation for rec ...... mparison to bevacizumab alone.

@en

Salvage re-irradiation for rec ...... mparison to bevacizumab alone.

@nl

prefLabel

Salvage re-irradiation for rec ...... mparison to bevacizumab alone.

@en

Salvage re-irradiation for rec ...... mparison to bevacizumab alone.

@nl

P1476

Salvage re-irradiation for rec ...... mparison to bevacizumab alone.

@en

P2093

Alexandra J Golby

http://www.w3.org/2001/XMLSchema#string

Andrew D Norden

http://www.w3.org/2001/XMLSchema#string

Ayal A Aizer

http://www.w3.org/2001/XMLSchema#string

Brian M Alexander

http://www.w3.org/2001/XMLSchema#string

Diana D Shi

http://www.w3.org/2001/XMLSchema#string

E Antonio Chiocca

http://www.w3.org/2001/XMLSchema#string

Elizabeth B Claus

http://www.w3.org/2001/XMLSchema#string

Eudocia Q Lee

http://www.w3.org/2001/XMLSchema#string

Ian F Dunn

http://www.w3.org/2001/XMLSchema#string

Keith L Ligon

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.

Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.

Re-irradiation of recurrent glioblastoma multiforme using 11C-methionine PET/CT/MRI image fusion for hypofractionated stereotactic radiotherapy by intensity modulated radiation therapy.

Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas

Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiforme

Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas.

Reirradiation tolerance of the human brain.

Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience.

FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme.

P2888

s11060-017-2611-9

P304

581-591

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-017-2611-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

135

http://www.w3.org/2001/XMLSchema#string

P50

David A Reardon

P577

2017-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28975467

http://www.w3.org/2001/XMLSchema#string

P921

bevacizumab